Constellation Pharmaceuticals

Constellation Pharmaceuticals

A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using epigenetics for the development of therapeutics for the selective targeting and modulating of gene expression in tumor and immune cells.

Timeline

October 1, 2019
Constellation Pharmaceuticals raises a $65,000,000 venture round.
July 1, 2017
Constellation Pharmaceuticals raises a $48,500,000 series E round from The Column Group, Third Rock Ventures, Topspin Partners and Venrock.
December 9, 2015
Constellation Pharmaceuticals raises a $55,000,000 series E round from Solon Mack Capital, The Column Group, Third Rock Ventures, Topspin Partners and Venrock.
August 6, 2014
Constellation Pharmaceuticals raises a $5,000,000 series D round.
January 17, 2012
Constellation Pharmaceuticals raises a $95,000,000 series C round from Genentech.
June 2011
Constellation Pharmaceuticals raises a $15,000,000 series B round from Altitude Life Science Ventures, Sr One, The Column Group, Third Rock Ventures and Venrock.
June 7, 2010
Constellation Pharmaceuticals raises a $22,300,000 series B round from Altitude Life Science Ventures, Sr One, The Column Group, Third Rock Ventures and Venrock.
August 13, 2009
Constellation Pharmaceuticals raises a $17,200,000 series B round from Altitude Life Science Ventures, The Column, Third Rock Ventures and Venrock.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Constellation Pharmaceuticals, Inc. funding round, April 2018
100,000,000
April 2018
9 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Bill Bradley

Employee

Mark Lodish

Investor

Michael Cooper

Employee

Michael Hewitt

Employee

Natasha Girgis

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.